Both in Pharmaceuticals
Arcus Biosciences vs Vera Therapeutics
Over the past year RCUS returned −7.8% and VERA returned +8.9%; their daily moves had a correlation of 0.24.
RCUS −7.8% VERA +8.9%Growth of $1, one year, split-adjusted
| Metric | RCUS | VERA |
|---|---|---|
| Price | $18.19 | $30.98 |
| Market cap | $2.32B | $2.23B |
| Today | −2.26% | +1.47% |
| 1 month | −27.9% | 0.0% |
| 6 months | −29.2% | −12.0% |
| Year to date | −23.7% | −38.8% |
| 1 year | −10.3% | +5.5% |
| Revenue growth (YoY) | −74.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −222.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 19.8× | — |
| Net cash | $601.0M | $423.9M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 60.3% |
| Short % of float | 13.6% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).